Work Here?
Industries
Social Impact
Biotechnology
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Bethlehem, Pennsylvania
Founded
1987
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$137.6M
Above
Industry Average
Funded Over
2 Rounds
Health Insurance
Dental Insurance
Vision Insurance
Life Insurance
Disability Insurance
401(k) Retirement Plan
401(k) Company Match
Paid Vacation
Paid Sick Leave
Parental Leave
Mental Health Support
Training Programs
Hybrid Work Options
OraSure to present at the J.P Morgan Healthcare Conference.
OraSure Technologies announced the acquisition of Sherlock Biosciences, a move that is expected to enhance their portfolio with next-generation molecular diagnostics.
BETHLEHEM, Pa., Dec. 19, 2024 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (“OTI”) (NASDAQ: OSUR), a leader in point-of-need and home diagnostic tests and sample management solutions, today announced the acquisition of Sherlock Biosciences, Inc., a global health company bringing next-generation diagnostics to consumers and healthcare providers. This acquisition expands OraSure’s innovation pipeline with the addition of Sherlock’s molecular diagnostics platform, which is able to provide rapid results with strong sensitivity and specificity in a disposable format that is well-suited for over-the-counter usage. Sherlock’s first molecular self-test is for Chlamydia Trachomatis (CT) and Neisseria Gonorrhoeae (NG) which will expand OraSure’s portfolio of rapid diagnostics for sexually transmitted infections (STIs), subject to regulatory approvals. Test results are expected to be provided in under 30 minutes by analyzing DNA and RNA from self-collected swabs using isothermal amplification
OraSure Technologies has won a $7.5 million multiyear award from BARDA to develop a rapid antigen test for Marburg virus, according to a Monday press release.
"Jack Kenny possesses a broad range of experience in the diagnostics field, having served in roles responsible for acquisition integration, commercial leadership, and product management," said Kim Wilson, Senior Vice President, Executive Search and Partner at Slone Partners
Find jobs on Simplify and start your career today
Industries
Social Impact
Biotechnology
Healthcare
Company Size
201-500
Company Stage
IPO
Headquarters
Bethlehem, Pennsylvania
Founded
1987
Find jobs on Simplify and start your career today